Advanced search
Publication Cover
Biomarkers in Medicine Volume 13, 2019 - Issue 9
Submit an article Journal homepage
99
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Association Between High Gal-3 Serum Levels and Worsening of Renal Function in Chronic Heart Failure Outpatients

Massimo Iacoviello1 University Cardiology Unit, Cardiothoracic Department, Policlinic University Hospital, 70124, Bari, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9613-5062
ORCID Icon,
Francesca Di Serio2 Clinic Pathology Unit, Policlinic University Hospital, 70124, Bari, Italy
,
Caterina Rizzo3 Division of Cardiology and Cardiac Rehabilitation, Scientific Clinical Institutes Maugeri, IRCCS, Institute of Cassano delle Murge, 70020, Cassano delle Murge, Bari, Italy
,
Marta Leone4 Cardiology Unit, Santissima Annunziata Hospital, 74100, Taranto, Italy
,
Dario Grande5 Cardiology Department, Bari Local Health Service, 70123, Bari, Italy
,
Pietro Guida3 Division of Cardiology and Cardiac Rehabilitation, Scientific Clinical Institutes Maugeri, IRCCS, Institute of Cassano delle Murge, 70020, Cassano delle Murge, Bari, Italy
,
Margherita Ilaria Gioia5 Cardiology Department, Bari Local Health Service, 70123, Bari, Italy
,
Giuseppe Parisi5 Cardiology Department, Bari Local Health Service, 70123, Bari, Italy
,
Tiziana Leopizzi5 Cardiology Department, Bari Local Health Service, 70123, Bari, Italy
,
Pasquale Caldarola6 School of Cardiology, University of Bari, 70124, Bari, Italy
,
Marco Matteo Ciccone5 Cardiology Department, Bari Local Health Service, 70123, Bari, Italy
&
Loreto Gesualdo7 University Nephrology Unit, D.E.T.O., University of Bari, 70124, Bari, Italy
 show all
Pages 707-713 | Received 01 Oct 2018, Accepted 30 Apr 2019, Published online: 03 Jun 2019

References

  • Rubinstein N , IlarreguiJM, ToscanoMA, RabinovichGA. The role of galectins in the initiation, amplification and resolution of the inflammatory response. Tissue Antigens64(1), 1–12 (2004).
  • Sharma UC , PokharelS, van BrakelTJet al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation110(19), 3121–3128 (2004).
  • Vergaro G , DelFranco A, GiannoniAet al. Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy. Int. J. Cardiol.184, 96–100 (2015).
  • de Boer RA , LokDJ, JaarsmaTet al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann. Med.43(1), 60–68 (2015).
  • McEvoy JW , ChenY, HalushkaMKet al. Galectin-3 and risk of heart failure and death in blacks and whites. J. Am. Heart Assoc.5(5), e003079 (2016).
  • Grande D , LeoneM, RizzoCet al. A multiparametric approach based on NT-proBNP, ST2, and galectin-3 for stratifying one year prognosis of chronic heart failure outpatients. J. Cardiovasc. Dev. Dis.4(3), E0009 (2017).
  • Henderson NC , MacKinnonAC, FarnworthSLet al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am. J. Pathol.172(2), 288–298 (2008).
  • O'Seaghdha CM , HwangSJ, HoJE, VasanRS, LevyD, FoxCS. Elevated galectin-3 precedes the development of CKD. J. Am. Soc. Nephrol.24(9), 1470–1477 (2013).
  • Rebholz CM , SelvinE, LiangMet al. Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease. Kidney Int.93(1), 252–259 (2018).
  • Gopal DM , KommineniM, AyalonNet al. Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure. J. Am. Heart Assoc.1(3), e000760 (2012).
  • Iacoviello M , AspromonteN, LeoneMet al. Galectin-3 serum levels are independently associated with microalbuminuria in chronic heart failure outpatients. Res. Cardiovasc. Med.5(1), e28952 (2015).
  • Ponikowski P , VoorsAA, AnkerSDet al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail.18(8), 891–975 (2016).
  • Rudski LG , LaiWW, AfilaloJet al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr.23(7), 685–713 (2010).
  • Levey AS, LA, SchmidCHet al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med.150(9), 604–612 (2009).
  • KDOQI . KDOQI Clinical Practice Guidelines and Clinical Practice recommendations for diabetes and chronic kidney disease. Am. J. Kidney Dis.49(2), S12–S154 (2007).
  • Damman K , TangWH, TestaniJM, McMurrayJJ. Terminology and definition of changes renal function in heart failure. Eur. Heart J.35(48), 3413–3416 (2014).
  • Laird N , WareJ. Random-effects models for longitudinal data. Biometrics38(4), 963–974 (1982).
  • Hillege HL , GirbesAR, de KamPJet al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation102(2), 203–210 (2000).
  • Damman K , VoorsAA, NavisG, van VeldhuisenDJ, HillegeHL. Current and novel renal biomarkers in heart failure. Heart Fail. Rev.17(2), 241–250 (2012).
  • Damman K , KalraPR, HillegeH. Pathophysiological mechanisms contributing to renal dysfunction in chronic heart failure. J. Ren. Care36(1), 18–26 (2010).
  • Tang WH , ShresthaK, ShaoZet al. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival. Am. J. Cardiol.108(3), 385–390 (2011).
  • Karayannis G , TriposkiadisF, SkoularigisJ, GeorgouliasP, ButlerJ, GiamouzisG. The emerging role of galectin-3 and ST2 in heart failure: practical considerations and pitfalls using novel biomarkers. Curr. Heart Fail. Rep.10(4), 441–449 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.